The global bioelectric medicine market size is projected to reach around US$ 36 billion by 2030 and is expected to grow at an impressive double-digit rate of 7.18% from 2022 to 2030.
Bioelectronics medical market is expected to grow during the forecast period pertaining to the rise in the number of chronic diseases which are mostly prevalent in the genetic population.
The study includes drivers and restraints of this market. The study provides an analysis of the global bioelectric medicine market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1788
Report Scope of the Bioelectric Medicine Market
| Report Coverage | Details |
| Market Size by 2030 | USD 36 Billion |
| CAGR from 2022 to 2030 | CAGR of 7.18% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global bioelectric medicine market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global bioelectric medicine market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global bioelectric medicine market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for bioelectric medicine are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global bioelectric medicine market include:
- Medtronic plc (Ireland)
- Abbott Laboratories, Inc. (US)
- Boston Scientific Corporation (US)
- Cochlear Ltd. (Australia)
- LivaNova PLC (UK)
- Soterix Medical Inc. (US)
- Bioinduction Ltd. (UK)
- GiMer Medical (Taiwan)
- Cefaly (Belgium)
- BioControl Medical (Israel)
- TVNS Technologies GmbH (Germany)
Market Segmentation:
By Product
- Implantable Cardioverter Defibrillators
- Cardiac Pacemakers
- Transcutaneous Electrical Nerve Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Cochlear implants
- Spinal cord stimulators
- Deep brain stimulators
By Type
- Implantable
- Noninvasive
By Application
- Arrhythmia
- Depression
- Treatment-resistant depression
- Epilepsy
- Pain management
- Tremor
- Urinary and fecal incontinence
- Sensorineural hearing loss
- Parkinson’s disease
- Others
By End User
- Hospitals
- Individual Users
- Homecare Centers
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Regional Analysis:
The geographical analysis of the global bioelectric medicine market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global bioelectric medicine Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global bioelectric medicine market in 2030?
- What is the expected CAGR for the bioelectric medicine market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global bioelectric medicine market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioelectric Medicine Market
5.1. COVID-19 Landscape: Bioelectric Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioelectric Medicine Market, By Product
8.1. Bioelectric Medicine Market, by Product, 2022-2030
8.1.1. Implantable Cardioverter Defibrillators
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Cardiac Pacemakers
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Transcutaneous Electrical Nerve Stimulators
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Sacral Nerve Stimulators
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Vagus Nerve Stimulators
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Cochlear implants
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Spinal cord stimulators
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Deep brain stimulators
8.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Bioelectric Medicine Market, By Type
9.1. Bioelectric Medicine Market, by Type e, 2022-2030
9.1.1. Implantable
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Noninvasive
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Bioelectric Medicine Market, By Application
10.1. Bioelectric Medicine Market, by Application, 2022-2030
10.1.1. Arrhythmia
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Depression
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Treatment-resistant depression
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Epilepsy
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Pain management
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Tremor
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Urinary and fecal incontinence
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Sensorineural hearing loss
10.1.8.1. Market Revenue and Forecast (2017-2030)
10.1.9. Parkinson’s disease
10.1.9.1. Market Revenue and Forecast (2017-2030)
10.1.10. Others
10.1.10.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Bioelectric Medicine Market, By End User
11.1. Bioelectric Medicine Market, by End User, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Individual Users
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Homecare Centers
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Ambulatory Surgical Centers
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Specialty Clinics
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Bioelectric Medicine Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Type (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Type (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Type (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Type (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Type (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Type (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Type (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Type (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Type (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Type (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Type (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Type (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Type (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Type (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Type (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Type (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Type (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Type (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Type (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Type (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Type (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
Chapter 13. Company Profiles
13.1. Medtronic plc (Ireland)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Abbott Laboratories, Inc. (US)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Boston Scientific Corporation (US)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Cochlear Ltd. (Australia)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. LivaNova PLC (UK)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Soterix Medical Inc. (US)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bioinduction Ltd. (UK)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. GiMer Medical (Taiwan)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cefaly (Belgium)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. BioControl Medical (Israel)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments